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Blood Pressures and lndxes of Anglogenesis, Endothelial Dysfunction and lluombogenesis 
Healthy Controls Hypertensive Patients p Value 
Systolic BP (mmHg) 134+ 11 161 * 21 <O.OOl 
Diastolic BP 81 *7 95 * 16 0.002 
(mmHg) 
FMD (X) 11.9kll.6 3.9 * 5.8 0.002 
vWf (IU/dl) 111.6 * 32.9 103.7 * 27.1 0.330 
VEGF @g/ml) 96 [60-l 301 105 [53-l 2801 0.358 
sFll-1 @g/ml) 1.3 [0.5-2.61 1.5 [0.5-l 111 0.217 
Tie-2 @g/ml) 4.4 [2.7-6.31 7.25 [3.5-37.51 0.043 
TF @@ml) 15 [Il.161 19 [13-321 0.023 
Values expressed es meanistandard deviation or median [interquartile range] and 
analysed by Unpaired T Test or Mann Whitney es appropriate 
lowest quinttle of normal FG. This finding suggests that improving glycemic control may 
mitigate the proinflammatory state in subjects with diabetes and insulin resistance. 
5:15 p.m. Fasting dwosecdagory 
832-6 Long-Term Follow-Up of Hypertensive Patients With 
Angiographically Normal Coronary Arteries: Prognostic 
Value of Epicardial Coronary Endothelial Dysfunction 
Alain Nitenberq, Denis Chemla, lsabelle Antony, CHU Jean Verdier, Bondy, France, 
CHU Bic&re, Le Kremlin-BicBtre, France 
Background: epicardial coronary endothelial dysfunction independently predicts cardio- 
vascular events in patients with coronary risk factors and without coronary atherosclero- 
sis. This study was designed to evaluate outcome of hypertensive patients (HP) on the 
basis of their epicardial coronary endothelial function. 
Methods: 68 control subjects (CS), 53 males, 15 females (46.6i7.6 years) and 63 HP, 54 
males, 29 females (51.3i7.9 years) with angiographically normal coronary arteries and 
without any other coronary risk factor underwent epicardial coronary reactivity assess- 
ment to cold pressor test (CPT) using quantitative coronary angiography. Unpredictable 
cardiovascular events (CVE) (sudden cardiac death, stable and unstable angina, myo- 
cardial Infarction, stroke, angioplasty, coronary artery surgery) were recorded with a 
mean follow-up of 115 months (range 64.132). 
Results: in CS, dilation occurred in &X2%, no change in 11.8% (mean diameter change: 
+14.6t9.3%) and there was no constriction. In HP, coronary artery dilation occurred in 
13.3%, no change in 25.3% (mean diameter change: +10.9+11.2%). and constriction in 
61.4% (mean diameter change: -12.7+3.4%). Endothelium-independent dilation to 
nitrates was normal in the 2 arouos /26.7+12.6% and 25.&l 1.9%. respectivelv. NS). In _ . 
CS, there was 3 CVE in 2 subjects (2.9%). In HP, there was 17 CVE III 12 patients 
(14.5%. o<O.Ol vs CSI. and in this orouo there was 15 CVE in the lo/51 oatients H9.6%) 
. I  
, .  ” I  
with coronary artery constriction, and 2 CVE in the 2/33 patients (6.3%) with no change 
or dilation (p<O.O5). 
Conclusion: in hypertensive patients with angiographically normal coronary arteries and 
without other coronary risk factors, epicardial coronary endothelial dysfunction assessed 
by a simple cold pressor test is predictive of long-term cardiovascular events. 
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840-1 Relation Between Fasting Glucose and C-Reactive 
Protein in Middle-Aged Subjects 
Doron Aronson Peter Bartha, Oren Zlnder, Arthur Kerner, Ella Shitman, Gerald J. Brook, 
Yishai Levi, Rambam. Haifa, Israel 
Introduction: Elevation of C-reactive protein (CRP) is associated with components of 
the metabolic syndrome, and especially with measures of obesity. Hyperglycemia can 
stimulate release of cytokines from venous cell types including adipocytes. However, the 
relation between glycemic status and CRP is not known. Methods: We studied the rela- 
tion of high-sensitivity CRP to fasting glucose (FG) and components of the metabolic 
syndrome in a population-based cross secbonal study (n = 1000; age, 50 + 9 years). 
Results: CRP increased continuously from the lowest quartile of normal FG to impaired 
FG and to diabetes (Figure). Increasing CRP with higher FG levels was apparent even 
among subjects with FG in the normal range (P = 0.039 for trend). Subjects with FG in 
the upper quartile of normal FG had higher CRP compared to subjects in the lower quar- 
tile (P= 0.035). There was a positive crude correlation between CRP and smoking, post- 
menopausal hormone use, body mass index, FG. triglycerides, hypertension, and uric 
acid (P= 0.002 to O.OOOl), and a negative correlation with HDL (PC 0.0001) and physi- 
cal activity (P = 0.002). After adjustment for potential confounders in a stepwise multivari- 
ate linear regression, FG remained independently related to CRP (P= 0.019). 
Conclusion: CRP increases continuously across the spectrum of FG, beginning in the 
8:45 a.m. 
840-2 Age Dependent Association Between High Sensitivity 
C-Reactive Protein and Tumor Necrosis Factor 
Functional Variants 
Fernando Aratiio, Alexandre C. Pereira, Gloria F. Motta, Daniela L. Jardim, Jose E. 
Krieger, Alfred0 J. Mansur, Heart Institute - InCor, SBo Paula, Brazil 
High sensitivity C-Reactive protein (hs-CRP) is a promising biochemical marker for pre- 
diction of coronary events. Genetic factors may influence hs-CRP concentration. We 
hypothesized that a genetic variant at position-306 in the promoter region of the TNF 
alpha gene (TNFA2 allele), which is related to increased circulating levels of TNF, may 
be associated with higher hs-CRP in a Brazilian population. This study enrolled 664 
healthy adults volunteers, 295 men (43. 1%) and 369 women (57. l%), designed to 
quantify environmental and genetic variables associated with serum hs-CRP. Ethnic dis- 
tribution was concordant with the ethnic distribution in the country. TNF -306 genotype 
was obtained through PCR amplification and restriction enzyme digestion in DNA from 
peripheral leucocytes. TNFA Alleles were in Hardy-Weinberg equilibrium in this sample. 
Ethnic&y was the single demographic variable with different distribution regarding harbor- 
ing or not the TNFAP allele (p=O.O3). There was no statistically significant difference 
between the individuals with or without the TNFAP allele and hs-CRP serum concentra- 
tion. However, there was a tendency for higher hs-CRP serum levels in the TNFA2 group 
and a higher frequency of Individuals with the TNFAP allele in hs-CRP quartile 4. 
Through ANOVA factorial modeling using log transformed hs-CRP serum level as the 
dependent variable a significant association between hs-CRP and the presence of 
TNFAP allele was discloused after stratifying our analysis for age quartiles (p= 0.01). 
TNFA genotype was significantly associated with hs-CRP serum levels in the fourth 
quartile of age (geometric mean serum level in this quartile 0.096 (0.02) for TNFA11 
TNFAl individuals and 0.196 (0.051) for individuals harbonng the TNFAP allele). This 
association remained statistically significant after adjustmet for ethnicity (p = 0.03). 
Finally, the presence of TNFAP allele in this age group increased the odds of being in the 
fourth quartile of hs-CRP concentration (p value = 0.04, OR = 5.1, 95% Cl = 1.1 
24.9).These data are consistent with an association between a functional genetic variant 
of the TNF alpha gene and hs-CRP levels at particular age groups 
9:00 a.m. 
840-3 Matrix Metalloproteinases and Their Inhibitors in 
Premature Coronary Atherosclerosis: Relation With 
Inflammation and Metabolic Markers 
Samuele Nanni, Giovanni Melandri. Roeland Hanemaaijer, Vittorio Cervi, Luciana 
Tom&, Chiara Melloni, Pierluigi Tricoci, Angelo Branzi, Institute of Cardiology, Bologna, 
Italy. T.N.O.-PG, Leiden, The Netherlands 
Background: little is known on determinants of matrix metalloproteinases (MMPs) plasma 
concentration and activity in coronary artery disease (CAD). 
Methods: we studied 80 male patients (pts) with premature (5 55 years) CAD (either 
myocardial infarction or angina with angiographic evidence of CAD) and 40 healthy male 
controls of similar age. The pts were subdivided into three groups as follows: 1) 20 con- 
secutive pts with ST elevation acute myocardial infarction (STEMI), 2) 29 consecutive pts 
with unstable angina (UA) or non-STEM1 (UAINSTEMI), 3) 31 consecutive pts with stable 
CAD. 
MMP-2 (i.e gelatinase A) and MMP-9 (i.e. gelatinase B) plasma total activities were mea- 
sured along with concentrations of MMP-2, MMP-3 (i.e. stromelysin-1), MMP-9 and spe- 
cific tissue inhibitors of MMPs. such as TIMP-1 and TIMP-2. Inflammation and metabolic 
markers were also evaluated. 
Results: MMPs and TlMPs data are deplcted in table 1. MMP-2 total activity was lower 
both in the whole pts population and in ACS pts compared to controls (both p < 0.002). 
MMP-2 total activity inversely correlated with haptoglobin and blood glucose ( p 0.032). 
TIMP-1 strongly correlated with blood glucose and both C-reactive protein and haptoglo- 
bin (all psO.005). 
Conclusion: 
in patients with premature CAD MMP-9 and TIMP-1 concentrations are increased, while 
TIMP-2 concentration and MMP-2 total activity are decreased. TIMP-1 and MMP-2 total 
activity strongly correlated with inflammation markers and with blood glucose levels. 
